Alder Biopharmaceuticals is gearing up to wage a commercial battle against some of the world's largest pharmaceutical companies in a market that could be worth billions if any of the companies can get it right. Alder is hoping dosing and administration will give it an advantage over the likes of Teva Pharmaceuticals, Eli Lilly & Co. and Amgen.
Alder Readies To Take On Teva, Others In Migraine